Request Your Free Report Now:

"Infectious Diseases: Global Clinical Trial Landscape (2025)"

Download this Report to Learn More

Infectious diseases account for approximately 14 million deaths each year, disproportionately impacting low- and middle-income countries. Novotech’s latest report explores how the clinical trial landscape is evolving to meet these challenges and drive global health progress.

Key insights:

• Nearly 2,000 infectious disease trials initiated since 2020
• Asia-Pacific leads with 70% CAGR; North America follows with 52%
• Over 900 trials in viral infections including COVID-19, HIV/AIDS, hepatitis B, and RSV
• Emerging innovations: AI-driven discovery and decentralized trial models
• Regulatory harmonization and platform trials accelerating development timelines
• Antimicrobial resistance remains an urgent priority

Offered Free by: Novotech
See All Resources from: Novotech